Imagen de Portada

A shock with skin necrosis is not always necrotising soft tissue infection

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Aurore Vanden Bulcke, Bérénice Tiquet, Stefania Magnoni, Nicolas Mongardon
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	British Journal of Haematology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Bone marrow necrosis and fat embolism in critically ill patients with acute complications of sickle cell disease: A retrospective cohort study
por: Ségolène Gendreau, et al.
Publicado: (2025)

Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study
por: Augustin Boudry, et al.
Publicado: (2025)

Atypical mast cells and multiple myeloma: An ambiguous alliance with diagnostic implications
por: Jean‐Baptiste Rieu, et al.
Publicado: (2026)

Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study
por: Maddalena Casale, et al.
Publicado: (2024)

Platelet phagocytosis in acute Dengue infection
por: Giuseppe Colucci, et al.
Publicado: (2025)

Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline
por: Shamez N. Ladhani, et al.
Publicado: (2024)

Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies
por: Hind Rafei, et al.
Publicado: (2024)

Neutrophil extra‐cellular traps in blood during the response to Acinetobacter infection following chemotherapy
por: Tsutomu Nagaoka, et al.
Publicado: (2024)

Outcomes of dengue infection in adults with underlying haematological diseases in Brazil during 2024 and 2025
por: K. Tozatto‐Maio, et al.
Publicado: (2026)

Molecular characterization of diffuse large B‐cell lymphomas associated with hepatitis C virus infection
por: Roberta Sciarra, et al.
Publicado: (2024)

Late infections after high‐dose therapy and autologous stem cell transplantation for lymphoma: A Danish population‐based study
por: Freja Tang Severinsen, et al.
Publicado: (2025)

Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state
por: Amrit S. Gonugunta, et al.
Publicado: (2024)

EASIX score predicts non‐relapse mortality and severe infection in elderly patients undergoing allo‐HSCT
por: Lizhen Liu, et al.
Publicado: (2025)

Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi‐international clinical trial AIEOP ‐ BFM ALL 2009
por: Andreas H. Groll, et al.
Publicado: (2026)

Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
por: Othman Salim Akhtar, et al.
Publicado: (2024)

Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis
por: Barbora Weinbergerová, et al.
Publicado: (2024)

Hepatitis E virus infection after CAR T‐cell treatment: An important complication in patients already facing significant health challenges
por: Vincent Mallet, et al.
Publicado: (2024)

Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy
por: Sophie de Tocqueville, et al.
Publicado: (2024)

Anti‐PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT‐like and VITT‐like characteristics
por: Phillip L. R. Nicolson, et al.
Publicado: (2025)

Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis
por: Jacopo Mariotti, et al.
Publicado: (2025)

Exposure to obinutuzumab does not affect outcomes of SARS ‐ CoV ‐2 infection in vaccinated patients with newly diagnosed advanced‐stage follicular lymphoma
por: A. Pinto, et al.
Publicado: (2024)

The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)
por: Francesco Baccelli, et al.
Publicado: (2025)

Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T‐cell period: Preservation of vaccine‐associated antibodies between 0 and 6 months
por: Gemma K. Reynolds, et al.
Publicado: (2024)

Guideline for the management of hepatitis B and C infection and subsequent liver disease surveillance (where indicated) in people with congenital bleeding disorders: A joint guideline from the British Society of Haematology and the British Viral Hepatitis Group
por: Ashley Brown, et al.
Publicado: (2025)

Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T‐cell lymphomas: A retrospective single‐centre experience
por: Filippo Bagnoli, et al.
Publicado: (2026)

Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients
por: Solenne Le Louet, et al.
Publicado: (2026)

Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative
por: Karthik A. Ganapathi, et al.
Publicado: (2024)

Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03
por: Aurore Perrot, et al.
Publicado: (2024)

Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib
por: Irene Trambusti, et al.
Publicado: (2024)

Polatuzumab vedotin and CD79B : A study of efficacy in R‐CHOP‐resistant diffuse large B‐cell lymphoma
por: Nicolas Munz, et al.
Publicado: (2025)

Iron trapping in macrophages reshapes the homeostasis of the haematopoietic system
por: Laura Crisafulli, et al.
Publicado: (2025)

Concurrence of mixed cryoglobulinaemia and cold agglutinin disease, and the putative role for a stereotyped immunoglobulin light chain
por: Ylenia A. Minafò, et al.
Publicado: (2025)

Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVDDD‐DI phase II study
por: Gaetano Corazzelli, et al.
Publicado: (2024)

Enitociclib ( VIP152 ), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma
por: Max J. Gordon, et al.
Publicado: (2025)

Aberrant antioxidant responses in B‐cell non‐Hodgkin lymphoma
por: Nicolas Vallet, et al.
Publicado: (2025)

Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study
por: Angelica Barone, et al.
Publicado: (2024)

Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse
por: Cyrille Touzeau, et al.
Publicado: (2025)

Successful autologous haematopoietic stem cell transplantation in a refractory anti‐myelin‐associated glycoprotein antibody neuropathy
por: Fanny Urbain, et al.
Publicado: (2024)

Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene
por: Antonio Marzollo, et al.
Publicado: (2024)

Controversies in the pathophysiology of leg ulcers in sickle cell disease
por: Judith Catella, et al.
Publicado: (2024)